DH - Definitive Healthcare Non-GAAP EPS of $0.08 beats by $0.02 revenue of $61M in-line

August, 14 2023 04:18 PM Definitive Healthcare Corp.

2023-08-14 16:18:48 ET

Definitive Healthcare press release ( NASDAQ: DH ): Q2 Non-GAAP EPS of $0.08 beats by $0.02 .
Revenue of $61M (+11.9% Y/Y) in-line.
Third Quarter 2023:
Revenue is expected to be in the range of $63.0 – $64.5 million, a 10-12% increase year over year.
Adjusted Operating Income is expected to be in the range of $16.0 – $17.0 million.
Adjusted EBITDA is expected to be in the range of $17.5 – $18.5 million.
Adjusted Net Income is expected to be $9.5 – $10.5 million.
Adjusted Net Income Per Diluted Share is expected to be $0.05 – $0.07 per share on approximately 156.9 million weighted-average shares outstanding.
Full Year 2023:
Revenue is expected to be in the range of $249.0 – $255.0 million, up 12% – 15% from prior year.
Adjusted Operating Income is expected to be in the range of $61.5 – $65.5 million.
Adjusted EBITDA is expected to be in the range of $67.0 – $71.0 million.
Adjusted Net Income is expected to be $30.0 – $34.0 million.
Adjusted Net Income Per Diluted Share is expected to be $0.19 – $0.23 per share on approximately 155.4 million weighted-average shares outstanding.

For further details see: